MENU
PTHS
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
Pelthos Therapeutics (PTHS) Ownership - Who owns Pelthos Therapeutics?
Pelthos Therapeutics Inc is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
101.76M
P/E Ratio
N/A
Total Cash
59.17K
Projected Growth
N/A
Total Debt
2.3M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.02
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
PTHS
Capitalization
102M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
59.2K
Total Cash/Share
0.02
Total Debt
2.31M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-6.49M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-14.66
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
67
Current Ratio
0.11
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-8.54M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-527.54
Shares Held By Institutions
246K
Shares Outstanding - Current
3.06M
Total Liabilities
7.32M
Total Volume MTD
N/A
Value
-1
Gain YTD
418.565
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information